A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Keith A. Choate, MD
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Eastern Health Monash University
Box Hill, Australia
- Veracity Clinical Research
Brisbane, Australia
- Royal Children'S Hospital
Parkville, Australia
- Premier Specialists Ptd Ltd
Sydney, Australia
- the Hospital for Sick Children
Toronto, Canada
- Dermatologie Pédiatrique
Paris, France
- Chu Charles Nicolle
Rouen, France
- Chu de Toulouse- Hospital Larrey
Toulouse, France
- Charite - Universitaetsmedizin Berlin
Berlin, Germany
- Universitätsklinkum Frankfurt
Frankfurt, Germany
- Kath. Kinderkrankenhaus Wilhelmstift
Hamburg, Germany
- Ludwig-Maximilians University
Munich, Germany
- Universitatsmedizin Rostock
Rostock, Germany
- Tel Aviv Sourasky Mc
Tel Aviv, Israel
- Hospital Clinic de Barcelona
Barcelona, Spain
- Clinica Universidad de Navarra (madrid)
Madrid, Spain
- Hospital Nino Jesus
Madrid, Spain
- Hospital Niño Jesús
Madrid, Spain
- Clinica Universidad de Navarra
Pamplona, Spain
- Dnipropetrovsk State Hospital of Dermatovenerology
Dnipro, Ukraine
- Medical Center "family Medicine Clinic"
Dnipro, Ukraine
- Medical Center of Private Enterprise "dzerkalo"
Dnipro, Ukraine
- Ternopil Regional Clinical Dermatovenereological Dispensary
Ternopil, Ukraine
- Tdc Pe "asclepius"
Uzhhorod, Ukraine
- Community Institution "zaporizhzhya Regional Dermatovenereology Clinical Hospital"
Zaporizhzhya, Ukraine
- Royal London Hospital Barts Health Nhs Trust
London, United Kingdom
- Tcr Medical Corporation
San Diego, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Northshore University Healthsystem
Skokie, Illinois, United States
- Dawes Fretzin Clinical Research Group, Llc
Indianapolis, Indiana, United States
- Dermassociates, Pc
Rockville, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Texas Dermatology and Laser Specialists
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2019
- Primary completion
- 3 Sept 2021
- Completion
- 3 Sept 2021
- Last update posted
- 14 Aug 2023
- Registered enrollment
- 65
- Registry id
- NCT03738800
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.